COVISTA INC
CVSANYSE🏆 #1157 by market capEarnings Oct 28US Equity
$125.98▼ $2.76 (−2.19%)
Market closed · at close1h—
24h▼ 2.2%
7d▼ 2.2%
14d▼ 5.7%
30d▼ 5.2%
1y▼ 0.5%
🏦Market Cap
$4.29B
Small Cap
📈Revenue Growth (YoY)
+9.7%
Slowing
📊Gross Margin
57.3%
Healthy
💵FCF Margin
17.6%
Healthy
⚖️P/S Ratio
2.4x
Cheap
Otter Score
53
Weak
Trading Snapshot
- Day Range
- $125.44 – $127.01
- 52-Week Range
- $86.97 – $156.26
- Volume
- $3.84B
- Avg Volume
- $4.50B
- Shares Outstanding
- 34.0M
- Next Earnings
- Oct 5, 2026
Fundamentals Snapshot
- Annual Revenue
- $1.81B
- Last Q Revenue
- $481M
- P/E Ratio
- 19.7
- P/S Ratio
- 2.4x
- EPS (TTM)
- $6.42
- Dividend Yield
- —
Why Investors Own CVSA
- ✓High-growth profile — revenue up +41.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 30% gross margin and 28% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$1.81B▲ +35.8% YoY
Gross Margin (TTM)
29.7%▼ −0.3% YoY
Operating Income (TTM)
$466M▲ +35.8% YoY
Free Cash Flow (TTM)
$504M▲ +35.8% YoY
About COVISTA INC
A company profile for COVISTA INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
53/100
Analyst Price Target
ⓘAverage Target
$165.86
▲ +31.7% Upside
High Target$195.41
Low Target$125.05
Based on 12 analysts
Latest News & Updates
🚀
Barron’s·2h ago
COVISTA INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift CVSA price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
Barron’s·1d ago
COVISTA INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.